159 related articles for article (PubMed ID: 38539515)
21. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of G9a induces DUSP4-dependent autophagic cell death in head and neck squamous cell carcinoma.
Li KC; Hua KT; Lin YS; Su CY; Ko JY; Hsiao M; Kuo ML; Tan CT
Mol Cancer; 2014 Jul; 13():172. PubMed ID: 25027955
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of radiomic signatures of head and neck squamous cell carcinoma molecular features and subtypes.
Huang C; Cintra M; Brennan K; Zhou M; Colevas AD; Fischbein N; Zhu S; Gevaert O
EBioMedicine; 2019 Jul; 45():70-80. PubMed ID: 31255659
[TBL] [Abstract][Full Text] [Related]
24. A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
Liu C; Guo T; Sakai A; Ren S; Fukusumi T; Ando M; Sadat S; Saito Y; Califano JA
Cancer; 2020 Feb; 126(4):737-748. PubMed ID: 31721164
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of key genes and signal pathways of human papilloma virus-related head and neck squamous cell carcinoma].
Wang KP; Yuan YJ; Zhu JQ; Li BL; Zhang TT
Zhonghua Kou Qiang Yi Xue Za Zhi; 2020 Aug; 55(8):571-577. PubMed ID: 32842349
[No Abstract] [Full Text] [Related]
26. Rapalogs induce non-apoptotic, autophagy-dependent cell death in HPV-negative TP53 mutant head and neck squamous cell carcinoma.
Alam MM; Marin Fermin J; Spiller PT; Burnett C; Rong X; Moore-Medlin T; Maxwell CO; Khandelwal AR; Nathan CO
Mol Carcinog; 2022 Jan; 61(1):33-44. PubMed ID: 34598317
[TBL] [Abstract][Full Text] [Related]
27. IRAK1 is a novel DEK transcriptional target and is essential for head and neck cancer cell survival.
Adams AK; Bolanos LC; Dexheimer PJ; Karns RA; Aronow BJ; Komurov K; Jegga AG; Casper KA; Patil YJ; Wilson KM; Starczynowski DT; Wells SI
Oncotarget; 2015 Dec; 6(41):43395-407. PubMed ID: 26527316
[TBL] [Abstract][Full Text] [Related]
28. All HPV-negative head and neck cancers are not the same: Analysis of the TCGA dataset reveals that anatomical sites have distinct mutation, transcriptome, hypoxia, and tumor microenvironment profiles.
Kim HAJ; Zeng PYF; Shaikh MH; Mundi N; Ghasemi F; Di Gravio E; Khan H; MacNeil D; Khan MI; Patel K; Mendez A; Yoo J; Fung K; Lang P; Palma DA; Mymryk JS; Barrett JW; Boutros PC; Nichols AC
Oral Oncol; 2021 May; 116():105260. PubMed ID: 33725617
[TBL] [Abstract][Full Text] [Related]
29. Histone methylation antagonism drives tumor immune evasion in squamous cell carcinomas.
Li Y; Goldberg EM; Chen X; Xu X; McGuire JT; Leuzzi G; Karagiannis D; Tate T; Farhangdoost N; Horth C; Dai E; Li Z; Zhang Z; Izar B; Que J; Ciccia A; Majewski J; Yoon AJ; Ailles L; Mendelsohn CL; Lu C
Mol Cell; 2022 Oct; 82(20):3901-3918.e7. PubMed ID: 36206767
[TBL] [Abstract][Full Text] [Related]
30. The H3.3 G34W oncohistone mutation increases K36 methylation by the protein lysine methyltransferase NSD1.
Bröhm A; Schoch T; Grünberger D; Khella MS; Schuhmacher MK; Weirich S; Jeltsch A
Biochimie; 2022 Jul; 198():86-91. PubMed ID: 35341929
[TBL] [Abstract][Full Text] [Related]
31. SMYD2 overexpression is associated with tumor cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas.
Ohtomo-Oda R; Komatsu S; Mori T; Sekine S; Hirajima S; Yoshimoto S; Kanai Y; Otsuji E; Ikeda E; Tsuda H
Hum Pathol; 2016 Mar; 49():145-55. PubMed ID: 26826421
[TBL] [Abstract][Full Text] [Related]
32. Harnessing the role of epigenetic histone modification in targeting head and neck squamous cell carcinoma.
Suchanti S; Stephen BJ; Awasthi S; Awasthi SK; Singh G; Singh A; Mishra R
Epigenomics; 2022 Mar; 14(5):279-293. PubMed ID: 35184601
[TBL] [Abstract][Full Text] [Related]
33. Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status.
Ghasemi F; Prokopec SD; MacNeil D; Mundi N; Gameiro SF; Howlett C; Stecho W; Plantinga P; Pinto N; Ruicci KM; Khan MI; Yoo J; Fung K; Sahovaler A; Palma DA; Winquist E; Mymryk JS; Barrett JW; Boutros PC; Nichols AC
JCI Insight; 2019 Jan; 4(1):. PubMed ID: 30626742
[TBL] [Abstract][Full Text] [Related]
34. EGFR overexpression increases radiotherapy response in HPV-positive head and neck cancer through inhibition of DNA damage repair and HPV E6 downregulation.
Alsahafi EN; Thavaraj S; Sarvestani N; Novoplansky O; Elkabets M; Ayaz B; Tavassoli M; Legends MF
Cancer Lett; 2021 Feb; 498():80-97. PubMed ID: 33137407
[TBL] [Abstract][Full Text] [Related]
35. NF-κB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma.
Gaykalova DA; Manola JB; Ozawa H; Zizkova V; Morton K; Bishop JA; Sharma R; Zhang C; Michailidi C; Considine M; Tan M; Fertig EJ; Hennessey PT; Ahn J; Koch WM; Westra WH; Khan Z; Chung CH; Ochs MF; Califano JA
Int J Cancer; 2015 Oct; 137(8):1879-89. PubMed ID: 25857630
[TBL] [Abstract][Full Text] [Related]
36. KB-68A7.1 Inhibits Hepatocellular Carcinoma Development Through Binding to NSD1 and Suppressing Wnt/β-Catenin Signalling.
Zhang S; Xu J; Cao H; Jiang M; Xiong J
Front Oncol; 2021; 11():808291. PubMed ID: 35127520
[TBL] [Abstract][Full Text] [Related]
37. Single-Cell Transcriptome Analysis Reveals Different Immune Signatures in HPV- and HPV + Driven Human Head and Neck Squamous Cell Carcinoma.
Li S; Wang Y; Sun R; Franceschi D; Pan H; Wei C; Ogbuehi AC; Lethaus B; Savkovic V; Gaus S; Zimmerer R; Ziebolz D; Schmalz G; Jiang X
J Immunol Res; 2022; 2022():2079389. PubMed ID: 36157879
[TBL] [Abstract][Full Text] [Related]
38. Decreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma.
Cheng H; Fertig EJ; Ozawa H; Hatakeyama H; Howard JD; Perez J; Considine M; Thakar M; Ranaweera R; Krigsfeld G; Chung CH
Cancer Biol Ther; 2015; 16(8):1252-8. PubMed ID: 26046389
[TBL] [Abstract][Full Text] [Related]
39. Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest.
Li C; Johnson DE
Cell Cycle; 2013 Mar; 12(6):923-34. PubMed ID: 23421999
[TBL] [Abstract][Full Text] [Related]
40. TMEM16A/ANO1 is differentially expressed in HPV-negative versus HPV-positive head and neck squamous cell carcinoma through promoter methylation.
Dixit R; Kemp C; Kulich S; Seethala R; Chiosea S; Ling S; Ha PK; Duvvuri U
Sci Rep; 2015 Nov; 5():16657. PubMed ID: 26563938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
